News & Alerts
-
Jan- 2024 -9 January
Bayer Pushes Forward with U.S. Expansion Despite Setback in Blood Thinner Drug Development
German pharmaceutical giant Bayer (BAYGn.DE) remains undeterred in its plans for expansion into the U.S., reaffirming its commitment to the…
Read More » -
9 January
GSK Expands Respiratory Portfolio through $1.4 Billion Aiolos Bio Deal
British pharmaceutical giant GlaxoSmithKline (GSK) announced a strategic move to bolster its respiratory diseases portfolio with the acquisition of Aiolos…
Read More » -
8 January
Technavio Predicts Significant Growth in Assisted Reproductive Technology (ART) Market
According to the latest report by Technavio Research, the Assisted Reproductive Technology (ART) Market is poised for substantial growth, expecting…
Read More » -
8 January
Projected Growth for Human Microbiome Therapeutics Market to Surpass USD 730 Million by 2027
The global human microbiome therapeutics market is poised for a groundbreaking surge, anticipating a substantial growth of USD 732.95 million…
Read More » -
8 January
Bayer’s Breakthrough Menopausal Relief Drug Shines Amidst Setbacks
In a significant turn of events for pharmaceutical giant Bayer, the company has announced promising results for its menopausal relief…
Read More » -
8 January
Elon Musk’s Ongoing Drug Use Sparks Boardroom Shockwaves
The Wall Street Journal has reported concerns among executives and board members at companies led by Elon Musk regarding his…
Read More » -
6 January
India Introduces Stricter Drug Manufacturing Standards in the Wake of Overseas Deaths
In response to a series of overseas deaths linked to drugs manufactured in India since 2022, the Indian government has…
Read More » -
6 January
Bolivia Achieves Record Cocaine Seizure, Uncovering Nearly 9 Tons Worth $224 Million Locally
In a groundbreaking development, Bolivia has announced the largest-ever cocaine seizure in the country, with officials revealing the interception of…
Read More » -
6 January
Sarepta Triumphs Over Regenxbio and UPenn in Patent Lawsuit for Duchenne Muscular Dystrophy Treatment
Delaware federal court ruled in favor of Sarepta Therapeutics, bringing an end to a patent lawsuit filed by Regenxbio and…
Read More » -
6 January
Ligand Pharma’s At-Home Viral Skin Infection Treatment Gains U.S. Approval
Ligand Pharmaceuticals Inc. has announced that its topical treatment for a viral skin infection, Zelsuvmi, has received approval from the…
Read More »
